New powdered plasma passes early safety check in healthy volunteers
NCT ID NCT05629338
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 32 times
Summary
This study tested the safety of a new spray-dried plasma product called FrontlineODP in 24 healthy volunteers. Participants received different amounts of the product, and researchers watched for side effects. The goal was to see if it is safe enough to move forward in testing for treating bleeding or clotting problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hoxworth Blood Center
Cincinnati, Ohio, 45267-0055, United States
-
Spaulding Clinical Research LLC
West Bend, Wisconsin, 53095, United States
-
Versiti Blood Center of Wisconsin
Milwaukee, Wisconsin, 53233, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.